LG41852-1Region imaged: Whole bodyActive
Basic Attributes
- Version First Released
- Pending promotion to Production status
- Parent Group
- LG41818-2 RadRegion:WholeBody
- Group Category
- Radiology
LOINC FHIR® API Example - ValueSet Request Get Info
https://fhir.loinc.org/ValueSet/?url=http://loinc.org/vs/LG41852-1
LOINC Terms in this Group
38268-9 | DXA Skeletal system Views for bone density |
39149-0 | XR Gastrointestinal tract and Pulmonary system Single view for foreign body |
39622-6 | SPECT Guidance for abscess localization of Whole body |
39623-4 | NM Guidance for abscess localization of Whole body |
39669-7 | NM Whole body Views W Tc-99m Arcitumomab IV |
39675-4 | SPECT Whole body for infection W Ga-67 IV |
39678-8 | SPECT Whole body for tumor W Ga-67 IV |
39680-4 | SPECT Whole body W Ga-67 IV |
39683-8 | NM Whole body Views W Ga-67 IV |
39686-1 | NM Whole body Views for lymphoma W Ga-67 IV |
39698-6 | NM Whole body Views W I-131 MIBG IV |
39748-9 | SPECT Whole body for tumor W Tc-99m Sestamibi IV |
39749-7 | NM Whole body Views for tumor W Tc-99m Sestamibi IV |
39762-0 | SPECT Guidance for localization of tumor of Whole body |
39763-8 | NM Guidance for localization of tumor of Whole body |
39816-4 | SPECT Whole body Bone |
39817-2 | Deprecated NM Whole body Bone Static Views |
39818-0 | NM Whole body Bone Views |
39825-5 | SPECT Whole body Bone marrow |
39826-3 | NM Whole body Bone marrow Views |
39827-1 | NM Whole body Views for endocrine tumor W I-131 MIBG IV |
39828-9 | NM Whole body Views for endocrine tumor W In-111 pentetreotide IV |
39829-7 | NM Whole body Views for tumor W Ga-67 IV |
39830-5 | NM Whole body Views for infection W Ga-67 IV |
39839-6 | SPECT Whole body W I-131 MIBG IV |
39840-4 | NM Whole body Delayed Views W I-131 MIBG IV |
39842-0 | NM Whole body Delayed Views W In-111 Satumomab IV |
39844-6 | SPECT Whole body W In-111 Satumomab IV |
39845-3 | NM Whole body Views W In-111 Satumomab IV |
39875-0 | NM Whole body Delayed Views W Ga-67 IV |
39881-8 | SPECT Whole body Bone 3 phase |
39882-6 | NM Whole body Bone 3 Phase Views |
41837-6 | SPECT Whole body W Tc-99m Arcitumomab IV |
42170-1 | NM Whole body Views for lymphoma |
42171-9 | NM Whole body Views for tumor |
42175-0 | NM Whole body Views |
42292-3 | SPECT Whole body for tumor W Tl-201 IV |
42305-3 | NM Whole body Views for tumor W Tl-201 IV |
42708-8 | NM Whole body Views W In-111 tiuxetan IV |
42711-2 | NM Whole body Views W In-111 tagged WBC IV |
43562-8 | NM Skeletal system.axial Views for bone density |
43563-6 | NM Skeletal system.peripheral Views for bone density |
44139-4 | PT Whole body |
46297-8 | SPECT Whole body |
46305-9 | CT Whole body |
46306-7 | CT Whole body W contrast IV |
46358-8 | MR Whole body |
58741-0 | PT Skull base to mid-thigh |
69237-6 | SPECT Whole body for tumor |
80499-7 | MR Whole body WO and W contrast IV |
81547-2 | SPECT Whole body W In-111 pentetreotide IV |
81551-4 | PET+CT Bone from skull base to mid-thigh W 18F-NaF IV |
81552-2 | PET+CT Whole body Bone W 18F-NaF IV |
81554-8 | PET+CT Guidance for localization of tumor of Skull base to mid-thigh-- W 18F-FDG IV |
81555-5 | PET+CT Guidance for localization of tumor of Whole body-- W 18F-FDG IV |
81560-5 | SPECT Whole body W In-111 capromab pendetide IV |
81583-7 | NM Whole body Views W Sm-153 IV |
81584-5 | NM Whole body Views W tagged WBC IV |
81586-0 | NM Whole body Views W Y-90 ibritumomab tiuxetan IV |
81588-6 | NM Whole body Views for thyroid tumor |
81589-4 | NM Whole body Views for infection or inflammation |
81598-5 | NM Whole body Views for thyroid tumor metastasis post therapy |
81599-3 | NM Guidance for multiple days for localization of tumor of Whole body |
82136-3 | NM Whole body Views for tumor W I-123 MIBG IV |
82805-3 | PET+CT Guidance for localization of tumor of Whole body-- W 18F-FDG IV and WO contrast |
82806-1 | PET+CT Guidance for localization of tumor of Whole body-- W 18F-FDG IV and W contrast IV |
82807-9 | PET+CT Guidance for localization of tumor of Skull vertex to mid-thigh-- W 18F-FDG IV and WO contrast |
82808-7 | PET+CT Guidance for localization of tumor of Skull base to mid-thigh-- W 18F-FDG IV and WO contrast |
82809-5 | PET+CT Guidance for localization of tumor of Skull base to mid-thigh-- W 18F-FDG IV and W contrast IV |
83012-5 | DXA Skeletal system.axial Views for bone density |
83013-3 | DXA Skeletal system.peripheral Views for bone density |
83014-1 | DXA Skeletal system.axial Views for bone density and vertebral fracture |
87915-5 | PET+CT Guidance for localization of tumor of Skull vertex to mid-thigh-- W 18F-FDG IV and W contrast IV |
89631-6 | SPECT+CT Guidance for localization of tumor of Whole body |
89842-9 | SPECT+CT Whole body |
90312-0 | SPECT+CT Skeletal system |
95924-7 | CT Skeletal system Multisection for bone density |
95925-4 | CT Skeletal system.axial Multisection for bone density |
95926-2 | CT Skeletal system.peripheral Multisection for bone density |
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright